Biosenta Inc.
ZRO
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 100.07% | -99.86% | 100.00% | 200.00% | -48,800.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 100.07% | -99.86% | 100.00% | 200.00% | -48,800.00% |
| Cost of Revenue | -50.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Gross Profit | 100.00% | -99.93% | 0.00% | 100.00% | -146,300.00% |
| SG&A Expenses | 24.70% | -27.60% | 83.56% | -1.93% | -23.53% |
| Depreciation & Amortization | -20.00% | -20.00% | -66.67% | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.29% | -29.48% | 71.17% | 0.22% | -29.82% |
| Operating Income | 26.07% | -47.14% | -71.27% | -0.05% | -19.00% |
| Income Before Tax | 11.46% | -8.40% | -29.00% | -21.20% | 86.56% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.46% | -8.40% | -29.00% | -21.20% | 86.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.46% | -8.40% | -29.00% | -21.20% | 86.56% |
| EBIT | 26.07% | -47.14% | -71.27% | -0.05% | -19.00% |
| EBITDA | 26.07% | -47.39% | -71.53% | -- | -- |
| EPS Basic | 16.46% | 7.91% | -7.46% | 1.53% | 85.09% |
| Normalized Basic EPS | 16.50% | 8.05% | -7.14% | 1.22% | -77.59% |
| EPS Diluted | 16.46% | 7.91% | -7.46% | 1.53% | 85.09% |
| Normalized Diluted EPS | 16.50% | 8.05% | -7.14% | 1.22% | -77.59% |
| Average Basic Shares Outstanding | 6.27% | 17.34% | 19.89% | 22.65% | -9.94% |
| Average Diluted Shares Outstanding | 6.27% | 17.34% | 19.89% | 22.65% | -9.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |